177Lu-DOTATATE PRRT in patients with metastatic neuroendocrine tumor and a single functioning kidney: Tolerability and effect on renal function

Simple item page
dc.contributor.authorRanade, R.
dc.contributor.authorBasu, Sandip
dc.date.accessioned2017-03-20T08:48:13Z
dc.date.available2017-03-20T08:48:13Z
dc.date.issued2016
dc.description.divisionRMCen
dc.format.extent6193 bytes
dc.format.mimetypetext/html
dc.identifier.sourceJournal of Nuclear Medicine Technology, 2016. Vol. 44 (2): pp. 65-69en
dc.identifier.urihttp://hdl.handle.net/123456789/14241
dc.language.isoenen
dc.subjectneuroendocrine tumoren
dc.subjectbone marrow metastasisen
dc.subjectpeptide receptor radionuclide therapy (PRRT)en
dc.subject177Lu-DOTATATEen
dc.title177Lu-DOTATATE PRRT in patients with metastatic neuroendocrine tumor and a single functioning kidney: Tolerability and effect on renal functionen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0926.htm
Size:
6.05 KB
Format:
Hypertext Markup Language
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

2016